Yoshitomo Yanagimoto
Toyonaka Municipal Hospital, Osaka International Cancer Institute
Papers
6
Total Citations
91
H-Index
4
About
Dr. Yoshitomo Yanagimoto is a leading surgical oncologist whose research focuses on advancing minimally invasive and perioperative treatments for gastric and esophagogastric junction (EGJ) cancer. He is best known for his pivotal role in the MONA LISA study (JCOG1907), a randomized phase III trial investigating whether robot-assisted gastrectomy offers superior outcomes over laparoscopic gastrectomy for patients with clinical stage T1-4a gastric cancer. This work addresses critical limitations of conventional laparoscopy, such as motion restriction and spatial perception difficulties. Dr. Yanagimoto also provides comprehensive, high-impact reviews of essential surgical and perioperative updates, synthesizing recent landmark trials that are reshaping treatment strategies for early and advanced-stage disease. His clinical research extends to the emerging field of targeted therapy, documenting both the efficacy and real-world adverse events of zolbetuximab-based chemotherapy for CLDN18.2-positive advanced gastric cancer, as well as its potential in conversion surgery. With over 90 citations across his most-cited works, Dr. Yanagimoto’s contributions are instrumental in defining the future of precision surgery and multimodal care for gastric cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6